Robert G Gourdie Selected Research

Capsules (Microcapsules)

1/2014	Impact of the controlled release of a connexin 43 peptide on corneal wound closure in an STZ model of type I diabetes.
10/2013	A synthetic connexin 43 mimetic peptide augments corneal wound healing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert G Gourdie Research Topics

Disease

14	Wounds and Injuries (Trauma) 01/2021 - 04/2008
10	Cicatrix (Scar) 01/2021 - 04/2008
8	Cardiac Arrhythmias (Arrythmia) 12/2021 - 10/2006
6	Neoplasms (Cancer) 05/2021 - 05/2015
6	Inflammation (Inflammations) 09/2017 - 10/2013
5	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2016
3	Ischemia 01/2020 - 01/2019
3	Myocardial Infarction 10/2016 - 06/2006
2	Edema (Dropsy) 12/2021 - 12/2021
2	Fibrosis (Cirrhosis) 05/2021 - 03/2013
2	Heart Diseases (Heart Disease) 05/2021 - 01/2016
2	Infarction (Infarctions) 01/2019 - 10/2016
2	Hypoxia (Hypoxemia) 01/2019 - 01/2019
2	Ulcer 03/2015 - 01/2015
2	Corneal Injuries 01/2014 - 10/2013
2	Sudden Death 03/2013 - 07/2011
1	Long QT syndrome type 3 12/2021
1	Cardiac Edema 12/2021
1	Stroke (Strokes) 05/2021
1	Reperfusion Injury 01/2019
1	Glioma (Gliomas) 01/2018
1	Foreign-Body Reaction 06/2015
1	Foreign Bodies (Foreign Body) 06/2015
1	Prostatic Neoplasms (Prostate Cancer) 05/2015
1	Diabetic Foot 03/2015
1	Leg Ulcer 01/2015
1	Contracture 10/2014
1	Hypertrophy 11/2011
1	Ventricular Tachycardia 07/2011
1	Epilepsy (Aura) 10/2006
1	Ventricular Remodeling 06/2006
1	Congenital Heart Defects (Congenital Heart Defect) 10/2004

Drug/Important Bio-Agent (IBA)

25	Connexin 43 (Connexin43)IBA 01/2022 - 10/2006
17	Peptides (Polypeptides)IBA 01/2022 - 03/2009
10	ConnexinsIBA 01/2022 - 03/2011
4	Pharmaceutical PreparationsIBA 05/2021 - 01/2014
3	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 01/2016
3	SodiumIBA 12/2021 - 01/2019
3	CalciumIBA 01/2020 - 01/2017
3	Poloxamer (Poloxamer 407)IBA 06/2015 - 10/2013
2	CollagenIBA 01/2021 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 10/2016 - 03/2015
2	Capsules (Microcapsules)IBA 01/2014 - 10/2013
1	Phosphotransferases (Kinase)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Voltage-Gated Sodium ChannelsIBA 12/2021
1	Amino Acids FDA Link 03/2020
1	Delayed-Action PreparationsIBA 03/2020
1	10-N-nonylacridinium orange (NAO)IBA 01/2019
1	erucylphosphocholineIBA 01/2019
1	Anti-Arrhythmia AgentsIBA 01/2019
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2019
1	AlbuminsIBA 01/2019
1	AcidsIBA 01/2019
1	PeptidomimeticsIBA 01/2018
1	Ion Channels (Ion Channel)IBA 10/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Sodium Channels (Sodium Channel)IBA 10/2015
1	Flecainide (Tambocor)FDA LinkGeneric 10/2015
1	Protein Isoforms (Isoforms)IBA 06/2015
1	Adenosine Triphosphate (ATP)IBA 06/2015
1	SiliconesIBA 06/2015
1	Streptozocin (Streptozotocin)FDA Link 01/2014
1	polyornithineIBA 01/2014
1	AlginatesIBA 01/2014
1	Therapeutic UsesIBA 01/2014
1	SolutionsIBA 01/2014
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 11/2011
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2011
1	Serine (L-Serine)FDA Link 05/2011
1	A-factor (Streptomyces)IBA 10/2006
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 06/2006
1	Matrix Metalloproteinases (MMPs)IBA 06/2006
1	Transcription Factors (Transcription Factor)IBA 10/2004

Therapy/Procedure

11	Therapeutics 01/2019 - 04/2008
1	Drug Therapy (Chemotherapy) 01/2022
1	Occlusive Dressings (Occlusive Dressing) 01/2017
1	Rejuvenation 10/2016
1	Topical Administration 03/2015
1	Compression Bandages 01/2015
1	Ligation 01/2013